Seeking Alpha

Rod Raynovich's  Instablog

Rod Raynovich
142 Followers
4 Following
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
raygent.com
  • Rayno Life Science Portfolio Dx And Tools: EXAS, ILMN,TMO 0 comments
    Oct 2, 2012 2:23 PM | about stocks: ILMN, EXAS, QDEL

    Molecular Plays Lead Rayno Dx Focus Stocks Up

    Illumina (ILMN) rose 4.5% today on "talk" that Roche will increase its buyout offer to $60. Roche told Bloomberg that it does not comment on rumors. Illumina was added to the Rayno Portfolio in 2/2/09 at a price of $29 and the buy was reiterated in 2012 in the low 40's. The last high bid by Roche was $51. Illumina is a leader in gene sequencing which is a $5.6B market and is expected to grow to $25.6B as genetic tests and additional diagnostic content is added to sequencing.

    In other action for 2012 Qiagen (QGEN) has recovered from lows and is up 37% YTD; Exact Sciences (EXAS) is up 40% YTD and is at all time highs.Quidel (QDEL) is also at YTD highs and has recently introduced its Sofia diagnostic assay platform.

    Cepheid (CPHD) is a premier diagnostic company with a broad platform of assays but is not on our list. We are looking for value in the low 30's.

    2012 OriginalPricePrice%PricePrice  
      Recomm Dec'10Ret7/1/1110/2/12%YTD 
              
    AbaxisABAX2/2/091526.857927.7737.938.6 
    CardioV.Sys.CSII11/5/107.1511.666315.4511.4514 
    CeleraCRA3/28/1076.318acquired  
    Exact SciEXAS12/10/105.65.986.88.4811.3640 
    GenProbeGPRO2/2/094558.353069.7982.5539.6acquired
    IlluminaILMN2/2/092963.341187651.267.7 
    ImmucorBLUD4/5/102019.83020.73acquired  
    AlereALR2/2/092536.64637.3519.640 
    MicroFluidicsMFLU7/6/100.771.3474acquired  
    NeoGenNEOG7/2/102641.035845.3342.839 
    QiagenQGEN3/15/1021.519.55-919.071937.5 
    QuidelQDEL6/16/1012.414.451615.318.6523.3 
    SequenomSQNM11/18/093.758.031147.443.5-21.6 
    SeraCareSRLS11/18/092.754.75733.77acquired  
    ThermoFishTMO7/25/1253.5  New59.432 
              

    Disclosure: I am long ILMN.

    Themes: Molecular Diagnostics Stocks: ILMN, EXAS, QDEL
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers
Posts by Themes
antibody drug conjugates (ADC), biomarkers, Biopharmaceuticals, biopharmaceuticals, Biotech bull market, Biotech stocks, Biotechnology, Biotechnology sector, Biotechnology Sector Analysis, Clinical Diagnostics, clinical diagnostics, Clinical diagnostics and imaging, Diagnostics and Tools, fund-holdings, Genomics, genomics, IBB, Life Science, life science, Life Science diagnostics and tools, life science stocks, Life science stocks, Life Science Stocks, Life sciences, Life Sciences, life sciences, life sciences longs, long-ideas, market-outlook, molecular diagnostics, Molecular Diagnostics, momentum stocks, personalized medicine, pharmacogenomics, portfolio-strategy-asset-allocation, venture capital
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.